Ithaca 20bkgd 202
160325 20ionica 20logo

Ionica Sciences

A highly adaptable infectious disease diagnostics platform, focusing first on Lyme Disease (IonLyme Test), with rapid expansion to other vector borne diseases.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Ithaca, NY, US
  • Currency USD
  • Founded February 2013
  • Employees 4
  • Incorporation Type C-corp
  • Website

Company Summary

Ionica Sciences is developing a highly adaptable diagnostics platform, combining the spectroscopic technique of surfaced enhanced Raman scattering (“SERS”) with high affinity DNA aptamers to bind disease-specific target molecules. The first application is IonLyme™, a test for Lyme Disease offering greatly improved clinical accuracy vs existing tests. The menu of tests can be rapidly expanded by adding/exchanging aptamers to target a new disease.